Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis
Open Access
- 17 September 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11
Abstract
Tuberous sclerosis complex (TSC) represents the prototypic monogenic disorder of the mammalian target of rapamycin (mTOR) pathway dysregulation. It provides the rational mechanistic basis of a direct link between gene mutation and brain pathology (structural and functional abnormalities) associated with a complex clinical phenotype including epilepsy, autism, and intellectual disability. So far, research conducted in TSC has been largely neuron-oriented. However, the neuropathological hallmarks of TSC and other malformations of cortical development also include major morphological and functional changes in glial cells involving astrocytes, oligodendrocytes, NG2 glia, and microglia. These cells and their interglial crosstalk may offer new insights into the common neurobiological mechanisms underlying epilepsy and the complex cognitive and behavioral comorbidities that are characteristic of the spectrum of mTOR-associated neurodevelopmental disorders. This review will focus on the role of glial dysfunction, the interaction between glia related to mTOR hyperactivity, and its contribution to epileptogenesis in TSC. Moreover, we will discuss how understanding glial abnormalities in TSC might give valuable insight into the pathophysiological mechanisms that could help to develop novel therapeutic approaches for TSC or other pathologies characterized by glial dysfunction and acquired mTOR hyperactivation.Keywords
Funding Information
- Stichting TSC Fonds
- Seventh Framework Programme (602102)
- H2020 Marie Skłodowska-Curie Actions
- Epilepsiefonds (16-05)
This publication has 257 references indexed in Scilit:
- Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsyNeurobiology of Disease, 2010
- Neuron-glia synapses in the brainBrain Research Reviews, 2010
- Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis ComplexNeurobiology of Disease, 2010
- Oligodendrocytes: biology and pathologyActa Neuropathologica, 2009
- Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complexNeurobiology of Disease, 2009
- Oxidative stress disrupts oligodendrocyte maturationJournal of Neuroscience Research, 2009
- Human fetal radial glia cells generate oligodendrocytes in vitroGlia, 2008
- Cell‐specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubersAnnals of Neurology, 2008
- Loss of the Tuberous Sclerosis Complex Tumor Suppressors Triggers the Unfolded Protein Response to Regulate Insulin Signaling and ApoptosisMolecular Cell, 2008
- Gap Junctions Couple Astrocytes and OligodendrocytesJournal of Molecular Neuroscience, 2008